AAPL348.35-2.34 (-0.67%) ▼|ABBV293.51+0.21 (+0.07%) ▲|ABT110.07-0.44 (-0.40%) ▼|ACN259.11+4.74 (+1.86%) ▲|ADBE235.00-2.32 (-0.98%) ▼|AMAT370.50-0.05 (-0.01%) ▼|AMD516.29+7.71 (+1.52%) ▲|AMGN463.98-1.25 (-0.27%) ▼|AMT189.97+0.97 (+0.51%) ▲|AMZN271.83+4.90 (+1.83%) ▲|AVGO332.43+12.95 (+4.05%) ▲|AXP324.46+0.15 (+0.04%) ▲|BA173.73+1.35 (+0.78%) ▲|BAC50.72+0.17 (+0.33%) ▲|BKNG160.63-2.86 (-1.75%) ▼|BLK1,218.13+3.42 (+0.28%) ▲|BMY62.42+0.28 (+0.45%) ▲|BNY150.86-0.37 (-0.24%) ▼|BRK-B584.08+8.83 (+1.54%) ▲|C122.24+0.27 (+0.22%) ▲|CAT582.73-16.15 (-2.70%) ▼|CL98.06+0.12 (+0.12%) ▲|CMCSA24.92+0.41 (+1.69%) ▲|COF195.82-2.76 (-1.39%) ▼|COP135.98+1.51 (+1.12%) ▲|COST1,067.23+1.05 (+0.10%) ▲|CRM212.17-2.78 (-1.29%) ▼|CSCO98.57-0.08 (-0.08%) ▼|CVS88.16+2.91 (+3.41%) ▲|CVX211.51+0.73 (+0.35%) ▲|DE688.59-2.70 (-0.39%) ▼|DHR235.25+0.13 (+0.06%) ▲|DIS119.04-0.08 (-0.07%) ▼|DUK128.91+0.81 (+0.63%) ▲|EMR168.14-1.38 (-0.81%) ▼|FDX319.59+0.75 (+0.23%) ▲|GD368.13+6.06 (+1.67%) ▲|GE337.27+1.73 (+0.51%) ▲|GEV786.30-43.04 (-5.19%) ▼|GILD170.21+0.89 (+0.53%) ▲|GM88.74-0.91 (-1.01%) ▼|GOOG284.86-1.16 (-0.40%) ▼|GOOGL287.34-0.81 (-0.28%) ▼|GS910.89+4.67 (+0.52%) ▲|HD350.54-2.88 (-0.81%) ▼|HON228.00-1.00 (-0.43%) ▼|IBM243.81-0.61 (-0.25%) ▼|INTC58.04-1.33 (-2.24%) ▼|INTU336.87-1.36 (-0.40%) ▼|ISRG448.80-11.76 (-2.55%) ▼|JNJ280.51-1.60 (-0.57%) ▼|JPM342.52+0.44 (+0.13%) ▲|KO96.78+0.75 (+0.78%) ▲|LIN521.36+1.03 (+0.20%) ▲|LLY1,431.67+19.72 (+1.40%) ▲|LMT602.46+14.27 (+2.43%) ▲|LOW231.12-0.98 (-0.42%) ▼|LRCX223.24+1.93 (+0.87%) ▲|MA658.60+2.79 (+0.42%) ▲|MCD281.73+0.29 (+0.10%) ▲|MDLZ66.12-0.33 (-0.49%) ▼|MDT101.24-1.55 (-1.51%) ▼|META644.39+3.02 (+0.47%) ▲|MMM189.55+0.92 (+0.49%) ▲|MO76.10+0.29 (+0.38%) ▲|MRK147.43-1.33 (-0.89%) ▼|MS187.46+0.36 (+0.19%) ▲|MSFT533.88-11.30 (-2.07%) ▼|MU718.99-14.16 (-1.93%) ▼|NEE86.22-0.65 (-0.74%) ▼|NFLX62.91-1.05 (-1.63%) ▼|NKE38.78-1.10 (-2.76%) ▼|NOW98.59-4.17 (-4.06%) ▼|NVDA168.59-10.08 (-5.64%) ▼|ORCL117.89-1.90 (-1.59%) ▼|PEP143.10+1.22 (+0.86%) ▲|PFE29.35+0.12 (+0.39%) ▲|PG168.65+0.33 (+0.20%) ▲|PLTR167.25-1.96 (-1.16%) ▼|PM194.23+1.11 (+0.57%) ▲|QCOM173.30+1.83 (+1.07%) ▲|RTX200.43+4.12 (+2.10%) ▲|SBUX109.36-0.09 (-0.08%) ▼|SCHW93.41+0.68 (+0.73%) ▲|SO93.43-0.14 (-0.15%) ▼|SPG234.27+1.26 (+0.54%) ▲|T21.88+0.08 (+0.37%) ▲|TMO716.60-5.04 (-0.70%) ▼|TMUS168.62-0.09 (-0.05%) ▼|TSLA378.04-0.01 (0.00%) ▼|TXN299.87+4.14 (+1.40%) ▲|UBER69.88-1.29 (-1.81%) ▼|UNH403.45+5.83 (+1.47%) ▲|UNP300.20+3.19 (+1.07%) ▲|UPS110.97+0.01 (+0.00%) ▲|USB60.77-0.18 (-0.30%) ▼|V422.99+1.61 (+0.38%) ▲|VZ46.29+0.23 (+0.49%) ▲|WFC85.88+0.39 (+0.45%) ▲|WMT125.56-0.10 (-0.08%) ▼|XOM164.63-0.10 (-0.06%) ▼|AAPL348.35-2.34 (-0.67%) ▼|ABBV293.51+0.21 (+0.07%) ▲|ABT110.07-0.44 (-0.40%) ▼|ACN259.11+4.74 (+1.86%) ▲|ADBE235.00-2.32 (-0.98%) ▼|AMAT370.50-0.05 (-0.01%) ▼|AMD516.29+7.71 (+1.52%) ▲|AMGN463.98-1.25 (-0.27%) ▼|AMT189.97+0.97 (+0.51%) ▲|AMZN271.83+4.90 (+1.83%) ▲|AVGO332.43+12.95 (+4.05%) ▲|AXP324.46+0.15 (+0.04%) ▲|BA173.73+1.35 (+0.78%) ▲|BAC50.72+0.17 (+0.33%) ▲|BKNG160.63-2.86 (-1.75%) ▼|BLK1,218.13+3.42 (+0.28%) ▲|BMY62.42+0.28 (+0.45%) ▲|BNY150.86-0.37 (-0.24%) ▼|BRK-B584.08+8.83 (+1.54%) ▲|C122.24+0.27 (+0.22%) ▲|CAT582.73-16.15 (-2.70%) ▼|CL98.06+0.12 (+0.12%) ▲|CMCSA24.92+0.41 (+1.69%) ▲|COF195.82-2.76 (-1.39%) ▼|COP135.98+1.51 (+1.12%) ▲|COST1,067.23+1.05 (+0.10%) ▲|CRM212.17-2.78 (-1.29%) ▼|CSCO98.57-0.08 (-0.08%) ▼|CVS88.16+2.91 (+3.41%) ▲|CVX211.51+0.73 (+0.35%) ▲|DE688.59-2.70 (-0.39%) ▼|DHR235.25+0.13 (+0.06%) ▲|DIS119.04-0.08 (-0.07%) ▼|DUK128.91+0.81 (+0.63%) ▲|EMR168.14-1.38 (-0.81%) ▼|FDX319.59+0.75 (+0.23%) ▲|GD368.13+6.06 (+1.67%) ▲|GE337.27+1.73 (+0.51%) ▲|GEV786.30-43.04 (-5.19%) ▼|GILD170.21+0.89 (+0.53%) ▲|GM88.74-0.91 (-1.01%) ▼|GOOG284.86-1.16 (-0.40%) ▼|GOOGL287.34-0.81 (-0.28%) ▼|GS910.89+4.67 (+0.52%) ▲|HD350.54-2.88 (-0.81%) ▼|HON228.00-1.00 (-0.43%) ▼|IBM243.81-0.61 (-0.25%) ▼|INTC58.04-1.33 (-2.24%) ▼|INTU336.87-1.36 (-0.40%) ▼|ISRG448.80-11.76 (-2.55%) ▼|JNJ280.51-1.60 (-0.57%) ▼|JPM342.52+0.44 (+0.13%) ▲|KO96.78+0.75 (+0.78%) ▲|LIN521.36+1.03 (+0.20%) ▲|LLY1,431.67+19.72 (+1.40%) ▲|LMT602.46+14.27 (+2.43%) ▲|LOW231.12-0.98 (-0.42%) ▼|LRCX223.24+1.93 (+0.87%) ▲|MA658.60+2.79 (+0.42%) ▲|MCD281.73+0.29 (+0.10%) ▲|MDLZ66.12-0.33 (-0.49%) ▼|MDT101.24-1.55 (-1.51%) ▼|META644.39+3.02 (+0.47%) ▲|MMM189.55+0.92 (+0.49%) ▲|MO76.10+0.29 (+0.38%) ▲|MRK147.43-1.33 (-0.89%) ▼|MS187.46+0.36 (+0.19%) ▲|MSFT533.88-11.30 (-2.07%) ▼|MU718.99-14.16 (-1.93%) ▼|NEE86.22-0.65 (-0.74%) ▼|NFLX62.91-1.05 (-1.63%) ▼|NKE38.78-1.10 (-2.76%) ▼|NOW98.59-4.17 (-4.06%) ▼|NVDA168.59-10.08 (-5.64%) ▼|ORCL117.89-1.90 (-1.59%) ▼|PEP143.10+1.22 (+0.86%) ▲|PFE29.35+0.12 (+0.39%) ▲|PG168.65+0.33 (+0.20%) ▲|PLTR167.25-1.96 (-1.16%) ▼|PM194.23+1.11 (+0.57%) ▲|QCOM173.30+1.83 (+1.07%) ▲|RTX200.43+4.12 (+2.10%) ▲|SBUX109.36-0.09 (-0.08%) ▼|SCHW93.41+0.68 (+0.73%) ▲|SO93.43-0.14 (-0.15%) ▼|SPG234.27+1.26 (+0.54%) ▲|T21.88+0.08 (+0.37%) ▲|TMO716.60-5.04 (-0.70%) ▼|TMUS168.62-0.09 (-0.05%) ▼|TSLA378.04-0.01 (0.00%) ▼|TXN299.87+4.14 (+1.40%) ▲|UBER69.88-1.29 (-1.81%) ▼|UNH403.45+5.83 (+1.47%) ▲|UNP300.20+3.19 (+1.07%) ▲|UPS110.97+0.01 (+0.00%) ▲|USB60.77-0.18 (-0.30%) ▼|V422.99+1.61 (+0.38%) ▲|VZ46.29+0.23 (+0.49%) ▲|WFC85.88+0.39 (+0.45%) ▲|WMT125.56-0.10 (-0.08%) ▼|XOM164.63-0.10 (-0.06%) ▼|
16.7 C
New York
Tuesday, November 10, 2026

Tag: company

newsFORsourcecompanycontentinformationreleases1IT

Successful UK market entry programme set to launch for third consecutive year at London Tech Week

West Midlands Growth Company (WMGC) inviting applications from eligible companies for its unique UK market entry programme, with 15 places available for 2025/26.Launch of...

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”), today announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets. Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up the development process and extending the global reach for this biosimilar candidate.

Wondershare EdrawMax V14.5 Debuts at GITEX Europe: AI-Powered Diagramming Revolutionizes Diagram Creation

BERLIN, June 5, 2025 /PRNewswire/ -- Recently, Wondershare unveiled the latest version of its popular diagramming software, EdrawMax V14.5, at GITEX Europe 2025, one of...

Tata Communications Unveils New Cable System to Supercharge Next-Gen Global Connectivity

MUMBAI, India, June 5, 2025 /PRNewswire/ -- In a major advancement for network connectivity for businesses across Asia and beyond, Tata Communications, a leading...

Sino Innovation Lab and MASSPHOTON Collaborate to Enhance Air Quality at China Hong Kong City with Advanced UVC LED Sterilization

HONG KONG, June 5, 2025 /PRNewswire/ -- MASSPHOTON LIMITED, a global leader in gallium nitride (GaN) semiconductor devices and digital disinfection technologies, has successfully...

Richemont publishes FY25 Annual Report and Non-Financial Report

5 JUNE 2025 

Sectra’s year-end report 2024/2025: Reporting solid growth in a time of change

LINKÖPING, Sweden, June 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is continuing to deliver results through high customer...

DNA Tower becomes world’s first tower company to offer battery capacity in electricity reserve markets with Elisa DES

Elisa Oyj / Elisa Industriq, Press Release 5 June 2025 HELSINKI, June 5, 2025 /PRNewswire/ -- DNA Tower Finland, a Telenor Towers company, has successfully...

Kingspan Ramps Up Planned US Roofing Investment to $1 billion

 STILLWATER, Okla. and CUMBERLAND, Md., June 5, 2025 /PRNewswire/ -- Kingspan Group plc, the global leader in high performance insulation and building envelope solutions,...

MemeCore Announces Strategic Entry into South Korea with Acquisition of KOSDAQ-Listed Company

SEOUL, South Korea, June 5, 2025 /PRNewswire/ -- MemeCore, the world's first Layer 1 blockchain purpose-built for the Meme 2.0 movement, has officially announced...

K Wave Media, Inc.(Nasdaq: KWM)(“K Wave” 또는 “Company”), 비트코인 중심의 재무 전략 지원 위해 5억 달러 상당의 주식 매매 계약 합의

KWM, 2024년 수익률 4,000% 돌파하며 세계 최고의 성과를 낸 주식이 된 Metaplanet Inc. 모델 따라 ‘한국의 메타플래닛’ 꿈꾼다 
KWM, 2024년 수익률 4,000% 돌파하며 세계 최고의 성과를 낸 주식이 된 Metaplanet Inc. 모델 따라 ‘한국의 메타플래닛’ 꿈꾼다

NBPE – Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

GSTS Expands in Europe with the World’s First AI-Powered Collaborative Optimisation Solution

MONTRÉAL, June 5, 2025 /CNW/ - Global Spatial Technology Solutions ("GSTS"), a Maritime AI company, is excited to announce the expansion of its solution...

AKWEL: ANNUAL GENERAL MEETING POSTPONED

        Champfromier, Wednesday, June 5, 2025

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers